BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5869468)

  • 1. [On the treatment with colibacterin in gel of patients with nonspecific ulcerative colitis].
    Iukhvidova ZhM; Levitan MKh; Marko OP
    Sov Med; 1965 Aug; 28(8):79-84. PubMed ID: 5869468
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of treatment of patients with nonspecific ulcerative colitis].
    Tsybulevskaia VI; Barats RL; Gorban' MT
    Vrach Delo; 1967 May; 5():128-9. PubMed ID: 5618519
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of highly concentrated colibacterin in the complex therapy of nonspecific ulcerative colitis].
    Iukhvidova ZhM; Levitan MKh; Blant ME; Marko OP; Komarova NA; Minchuk NV
    Sov Med; 1969 Jun; 32(6):107-11. PubMed ID: 4895913
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis.
    Langmead L; Feakins RM; Goldthorpe S; Holt H; Tsironi E; De Silva A; Jewell DP; Rampton DS
    Aliment Pharmacol Ther; 2004 Apr; 19(7):739-47. PubMed ID: 15043514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of ulcerative colitis by corticoids].
    Ljaljević J; Radić S; Burijan J
    Srp Arh Celok Lek; 1969 Jun; 97(6):601-5. PubMed ID: 5198719
    [No Abstract]   [Full Text] [Related]  

  • 6. [Salasopyrin treatment of patients with nonspecific ulcerative colitis].
    Levitan MKh
    Klin Med (Mosk); 1969 May; 47(5):102-6. PubMed ID: 4904549
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The bacteriological and immunological efficacy of biosporin in nonspecific ulcerative colitis].
    Cherniakova VI; Bereza NM; Selezneva SI; Chaplinskiĭ VIa; Kudriavtseva VE; Mosalova NM; Shevtsova ZI; Tropko LV; Boĭko TI
    Mikrobiol Zh (1978); 1993; 55(3):63-7. PubMed ID: 8355632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
    Mantzaris GJ; Archavlis E; Christoforidis P; Kourtessas D; Amberiadis P; Florakis N; Petraki K; Spiliadi C; Triantafyllou G
    Am J Gastroenterol; 1997 Mar; 92(3):454-6. PubMed ID: 9068468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of the immunomodulator thymalin in the treatment of nonspecific ulcerative colitis].
    Shakhnazarov AA; Khavinson VKh; Morozov VG
    Vrach Delo; 1984 Mar; (3):19-22. PubMed ID: 6547013
    [No Abstract]   [Full Text] [Related]  

  • 11. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive therapy in ulcerative rectocolitis. Long-term assessment of results].
    Aresu G; Mereu S; Frongia N; Casula G; Uccheddu A
    Minerva Med; 1982 Apr; 73(14):767-86. PubMed ID: 6122191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
    Shafer NP
    Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of prednisolone on the mucous membrane of the large intestine in patients with nonspecific ulcerative colitis].
    Saakian AG
    Vrach Delo; 1966 Aug; 8():116-8. PubMed ID: 5989129
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neocide therapy of nonspecific ulcerative colitis].
    Zhernakova TV
    Klin Med (Mosk); 1966 Nov; 44(11):111-4. PubMed ID: 6000029
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of Clostridium difficile infection in the relapse of ulcerative colitis].
    Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M
    An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.
    Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Papageorgiou A; Vassiliadis T; Giouleme O; Evgenidis N
    Aliment Pharmacol Ther; 2006 May; 23(10):1443-53. PubMed ID: 16669959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Double-blind study of treatment with SF 68 or with antibiotics in acute enteritis in adults].
    Alvisi V; Tralli M; Loponte A; Pavani F; Massari M
    Clin Ter; 1982 Jun; 101(6):581-6. PubMed ID: 6751663
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contemporary methods of conservative treatment of patients with nonspecific ulcerative colitis].
    Shchetinina IN
    Ter Arkh; 1973 Jul; 45(7):59-65. PubMed ID: 4755070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.